Cannabis Investor NewsSubscribe →
C
CIN Terminal
Cannabis Investor News
A CanIDeal Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home › Markets › Loading…
— —

iAnthus Capital Holdings

—
—
Live Price

CIN RESEARCH · DATED EVIDENCE

Dated financial evidence

iAnthus Capital Holdings: revenue expanded; follow the cash evidence.

The reported-period revenue series records USD 35.35m for the period ended June 30, 2026. That is 0.5% above the same reporting basis a year earlier. Cash and operating cash flow are available on a matching dated basis.

Latest financial observation 2026-06-30Price history through 2026-11-05Research checked 2026-11-06 13:30 UTC

The check time records a research refresh. Each financial figure and price keeps its own reporting date.

Compare like-for-like revenue

The reported-period revenue series records USD 35.35m for the period ended June 30, 2026. That is 0.5% above the same reporting basis a year earlier.

Revenue and profitability are separate

The matching reported-period net loss is USD 14.42m. This is the reported result for 2026-06-30, not a future earnings estimate.

Put cash beside operating cash flow

Period-end cash was USD 8.04m at 2026-06-30. The matching reported-period operating cash inflow was USD 761,000. Later financing and cash movements are not established by this snapshot.

Follow the primary disclosures

The available record includes 1 primary disclosure. The latest is 2026-07-01. This is the available feed record, not a claim of complete filing coverage.

Reported financial evidence

Latest retained observation for each measure. Reporting periods and currencies can differ.
MeasureReported value & unitPeriod & intervalEvidence basis
RevenueUSD 35.35mUnit: USDQuarterly seriesDated financial series
Cost of revenueUSD 19.25mUnit: USDQuarterly seriesDated financial series
Gross profitUSD 16.1mUnit: USDQuarterly seriesDated financial series
Operating incomeUSD -2.28mUnit: USDQuarterly seriesDated financial series
EBITDAUSD 2.49mUnit: USDQuarterly seriesDated financial series
Net incomeUSD -14.42mUnit: USDQuarterly seriesDated financial series
Cash balanceUSD 8.04mUnit: USDBalance at period endDated financial series
Total assetsUSD 258.43mUnit: USDBalance at period endDated financial series
Total liabilitiesUSD 389.17mUnit: USDBalance at period endDated financial series
Shareholders’ equityUSD -130.75mUnit: USDBalance at period endDated financial series
Operating cash flowUSD 761,000Unit: USDQuarterly seriesDated financial series
Free cash flowUSD -2.85mUnit: USDQuarterly seriesDated financial series

A balance at period end is not income over a period. “Quarterly series” follows the available classification; the source disclosure establishes the actual reporting interval.

What changed against the prior year

Only the same measure, unit, reporting frequency and prior-year period end are compared. A reported change is not an investment rating.

Revenue · Quarterly series

Increased +0.5%

2025-06-30
USD 35,185,000
2026-06-30
USD 35,349,000
Cost of revenue · Quarterly series

Increased +1.1%

2025-06-30
USD 19,033,000
2026-06-30
USD 19,251,000
Gross profit · Quarterly series

Decreased -0.3%

2025-06-30
USD 16,152,000
2026-06-30
USD 16,098,000
Operating income · Quarterly series

Increased

2025-06-30
USD -5,370,000
2026-06-30
USD -2,279,000
EBITDA · Quarterly series

Increased

2025-06-30
USD -774,000
2026-06-30
USD 2,485,873
Net income · Quarterly series

Loss narrowed

2025-06-30
USD -18,718,000
2026-06-30
USD -14,424,000
Cash balance · Balance at period end

Decreased -65.7%

2025-06-30
USD 23,463,000
2026-06-30
USD 8,038,000
Total assets · Balance at period end

Decreased -3.8%

2025-06-30
USD 268,676,000
2026-06-30
USD 258,425,000
Total liabilities · Balance at period end

Increased +12.3%

2025-06-30
USD 346,592,000
2026-06-30
USD 389,174,000
Shareholders’ equity · Balance at period end

Decreased

2025-06-30
USD -77,916,000
2026-06-30
USD -130,749,000
Operating cash flow · Quarterly series

Decreased -75.9%

2025-06-30
USD 3,159,000
2026-06-30
USD 761,000
Free cash flow · Quarterly series

Decreased

2025-06-30
USD -400,000
2026-06-30
USD -2,851,000

What to investigate next

  • Resolve the conflicting financial observations against the primary report.
  • Read the latest linked company disclosures and any reporting after the financial period.
  • Check post-period financing, share issuance and changes in cash before drawing a current valuation conclusion.

Evidence boundaries

  • Conflicting observations for the same concept, period and reporting basis are withheld.
  • Interim frequency is provider-classified. Generic form labels are not treated as proof of an SEC filing or a three-month reporting duration.
  • The earlier rating is not presented as a current conclusion. This report is rebuilt from dated evidence.

Primary company disclosures

Independent evidence summary. No broker consensus, price target or investment rating is manufactured. Research standards →

Price History · currency not supplied 5 Years
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

CONTINUE YOUR RESEARCH

Connect the next piece.